# MiRNDa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mirnda

- Headquarters: Tokyo, Japan
- Website: https://mirnda.biz
- Latest round: Seed (Aug 25, 2026)
- Investors on record: 1

## About

Founded in 2025 and based in Tokyo, Japan, MiRNDa, Inc. operates as a biotechnology and in vitro diagnostics developer. The company provides research and development of in vitro diagnostic medical devices, pharmaceuticals, and blood-based RNA modification analysis technology for early cancer detection and diagnosis.

## Funding rounds

- Seed, Aug 25, 2026 — Global Brain

## Investors

- Global Brain (https://capitalatlas.ai/funds/global-brain) — Seed